O A Bocharova, N S Ionov, I V Kazeev, V E Shevchenko, E V Bocharov, R V Karpova, O P Sheychenko, A A Aksyonov, S V Chulkova, V G Kucheryanu, A V Revishchin, G V Pavlova, V S Kosorukov, Dmitry Filimonov, Alexey Lagunin, V B Matveev, N V Pyatigorskaya, I S Stilidi, Vladimir Poroikov
Multiphytoadaptogen (MPhA) containing 70 major phytocomponents of different chemical classes from 40 medicinal plant extracts has been studied in vitro, in vivo and in clinical researches. Antiproliferative and anti-tumor activities have been shown against some tumors as well as evidence-based therapeutic effects against age-related pathologies. In addition, the neuroprotective, antioxidant, antimutagenic, radioprotective, and immunomodulatory effects of MPhA were confirmed. Many human diseases including cancer, degenerative and autoimmune disorders, diabetes and others are multifactorial...
September 8, 2022: Molecular Informatics